Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE

Kamal Gupta, Harsh Mehta, Hwasoon Kim, Amanda Stebbins, Lisa M. Wruck, Daniel Muñoz, Mark B. Effron, R. David Anderson, Carl J. Pepine, Sandeep K. Jain, Saket Girotra, Darren A. DeWalt, Jeff Whittle, Catherine P. Benziger, Peter Farrehi, Li Zhou, Kirk U. Knowlton, Tamar S. Polonsky, Steven M. Bradley, Robert A. HarringtonRussell L. Rothman, W. Schuyler Jones, Adrian F. Hernandez

Internal Medicine
Cardiology

Research output: Contribution to journal › Article › peer-review

Sort by
Weight
Alphabetically

Comparison of the effectiveness and safety of 2 aspirin doses in secondary prevention of cardiovascular outcomes in patients with chronic kidney disease: A subgroup analysis of ADAPTABLE

Fingerprint

Medicine & Life Sciences